Delivery Order SPE2DB22D2211-SPE2DB25FRTWB
Award Date
3/24/25
Potential Completion Date
3/25/25
Potential Value
$3.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $3,501.44, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the drug WEGOVY 0.5 MG/0.5 ML PEN 0.5ML. This is a firm-fixed-price delivery order contract with a completion date of February 18, 2025. The contract is not associated with a set-aside program. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,638.00, is a delivery order for the drug WEGOVY 1 MG/0.5 ML PEN 0.5ML. The contract has an ultimate completion date of January 16, 2025 and is a firm fixed-price contract. Amerisourcebergen is the prime contractor, and there is no indication of any set-aside designation for this award. The...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, is for the supply of the medication WEGOVY 1 MG/0.5 ML PEN 0.5ML. The contract, valued at $1,097.08, is a delivery order issued by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of April 25, 2024. The contract is a firm fixed-price arrangement, without any set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
The federal contract award is for $23,930.36 and was granted by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the drug WEGOVY 0.5 MG/0.5 ML PEN 0.5ML, and has a firm fixed price pricing type with an ultimate completion date of March 12, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award was made by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide 4565092218 units of the prescription drug WEGOVY 1.7 MG/0.75 ML PEN 0.75ML. The contract has a firm fixed price of $44,623.74 and an ultimate completion date of July 10, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as the primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,228.50 fixed-price delivery order is for the drug WEGOVY 0.5 MG/0.5 ML PEN 0.5ML, with a period of performance through March 3, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award, valued at $4,363.47, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order and has a Firm Fixed Price pricing type. It is for the supply of the medication WEGOVY 0.5 MG/0.5 ML PEN 0.5ML, with a performance period through March 24, 2025. The contract was awarded on March 21, 2025 and does not have a set-aside...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $2,497.17 with a firm fixed-price pricing type. It is for the supply of the drug WEGOVY 0.5 MG/0.5 ML PEN 0.5ML, with an ultimate completion date of January 16, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract, valued at $1,720.32, is for the delivery of the prescription drug WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The $3,372.80 firm fixed price delivery order is for the supply of the medication WEGOVY 1.7 MG/0.75 ML PEN 0.75ML. The contract has an ultimate completion date of July 16, 2024 and was awarded on July 15, 2024. Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation, holds a...